HDAC6 Protein

HDAC6 Protein

Pathway Diagram

Overview

HDAC6 (Histone Deacetylase 6) is a cytoplasmic zinc-dependent deacetylase enzyme that belongs to the class IIb histone deacetylase family. Unlike most histone deacetylases that function primarily in the nucleus, HDAC6 is uniquely localized to the cytoplasm where it regulates non-histone protein acetylation. The protein is encoded by the HDAC6 gene located on chromosome Xp11.23 and is composed of 1,215 amino acids. HDAC6 contains two tandem catalytic domains (DAC1 and DAC2) connected by a linker region, with an additional zinc-binding domain at its C-terminus. This structural organization distinguishes HDAC6 from other histone deacetylases and enables its specialized role in protein quality control and cytoskeletal dynamics.

Function/Biology

HDAC6 Protein

Pathway Diagram

Overview

HDAC6 (Histone Deacetylase 6) is a cytoplasmic zinc-dependent deacetylase enzyme that belongs to the class IIb histone deacetylase family. Unlike most histone deacetylases that function primarily in the nucleus, HDAC6 is uniquely localized to the cytoplasm where it regulates non-histone protein acetylation. The protein is encoded by the HDAC6 gene located on chromosome Xp11.23 and is composed of 1,215 amino acids. HDAC6 contains two tandem catalytic domains (DAC1 and DAC2) connected by a linker region, with an additional zinc-binding domain at its C-terminus. This structural organization distinguishes HDAC6 from other histone deacetylases and enables its specialized role in protein quality control and cytoskeletal dynamics.

Function/Biology

HDAC6 functions as a key regulator of protein acetylation in the cytoplasm, with major roles in aggresome formation, autophagy, and protein trafficking. The enzyme catalyzes the removal of acetyl groups from lysine residues on target proteins, thereby modulating their activity, localization, and interactions. Primary substrates of HDAC6 include α-tubulin, which regulates microtubule dynamics and stability; heat shock protein 90 (Hsp90), a molecular chaperone; and tau protein, which is involved in microtubule binding and stabilization.

The most well-characterized function of HDAC6 involves the formation and clearance of aggresomes—cytoplasmic inclusion bodies that sequester misfolded proteins. HDAC6 catalyzes α-tubulin deacetylation, reducing microtubule stability and facilitating the dynein motor protein-dependent transport of protein aggregates toward the centrosome for aggresome formation. This process represents an important cellular response to proteasomal stress and protein misfolding. Additionally, HDAC6 interacts with p62 (sequestosome-1), an autophagy adaptor protein that links ubiquitinated cargo to the autophagy machinery, further supporting the clearance of cellular aggregates.

Role in Neurodegeneration

HDAC6 dysfunction or dysregulation has emerged as a significant factor in multiple neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and Huntington's disease. In Alzheimer's disease, HDAC6 activity influences tau pathology through deacetylation of both α-tubulin and tau protein itself. Altered HDAC6 levels correlate with changes in tau phosphorylation and aggregation, central pathological hallmarks of the disease. In Parkinson's disease models, HDAC6 inhibition has shown neuroprotective effects by enhancing autophagy-mediated clearance of α-synuclein, the primary constituent of Lewy bodies.

In Huntington's disease, mutant huntingtin protein aggregates accumulate in neurons, and HDAC6 activity influences their processing through aggresome formation and autophagy. Experimental studies have demonstrated that HDAC6 inhibition or knockdown can reduce huntingtin aggregate toxicity and improve neuronal survival. The protective mechanism appears to involve both enhanced autophagy and improved mitochondrial function through altered acetylation of stress-response proteins.

Molecular Mechanisms

HDAC6-mediated neuroprotection operates through multiple interconnected pathways. The primary mechanism involves acetylation-dependent regulation of chaperone proteins and autophagy machinery. By deacetylating Hsp90, HDAC6 modulates its chaperone activity, influencing protein folding and aggregate processing. Deacetylation of α-tubulin affects microtubule dynamics, which impacts the trafficking of autophagosomes and the transport of cellular cargo, including misfolded proteins and damaged organelles.

HDAC6 also regulates autophagy through the mammalian target of rapamycin (mTOR) signaling pathway and directly influences the acetylation status of autophagy-related proteins. The enzyme's inhibition has been shown to enhance autophagic flux—the rate at which cells process and clear autophagy substrates—providing a potential therapeutic mechanism in aggregate-prone neurodegenerative diseases.

Clinical/Research Significance

HDAC6 represents an emerging therapeutic target in neurodegeneration research. Multiple HDAC6-selective inhibitors have been developed and are under investigation in preclinical and clinical studies for neurodegenerative diseases. These selective inhibitors offer advantages over pan-HDAC inhibitors by avoiding potential off-target effects in the nucleus. Research suggests that HDAC6 inhibitors may enhance neuronal resilience to proteotoxic stress, improve microtubule function, and promote aggregate clearance through autophagy enhancement.

Related Entities

• Histone Deacetylases (general class)
• Autophagy and Proteostasis
• Aggresome Formation
• Alpha-Tubulin and Microtubule Dynamics
• Huntingtin Protein
• Tau Protein
• Alpha-